Mami Nagashima

6.7k total citations
26 papers, 172 citations indexed

About

Mami Nagashima is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mami Nagashima has authored 26 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Mami Nagashima's work include SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (8 papers) and Viral gastroenteritis research and epidemiology (5 papers). Mami Nagashima is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (8 papers) and Viral gastroenteritis research and epidemiology (5 papers). Mami Nagashima collaborates with scholars based in Japan, Egypt and Thailand. Mami Nagashima's co-authors include Kenji Sadamasu, Y. Tabei, Yukiko Yoshida, Satoshi Morozumi, Kazuhisa Yoshimura, Yukiko Sasaki, Tomoko Yamamoto, Takeshi Ito, Satoshi Mori and Akemi Kai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and PLoS Pathogens.

In The Last Decade

Mami Nagashima

24 papers receiving 169 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mami Nagashima Japan 8 138 58 24 18 17 26 172
Jamie A. Murkey United States 4 50 0.4× 73 1.3× 20 0.8× 30 1.7× 17 1.0× 6 145
Giuditta De Lorenzo United Kingdom 9 151 1.1× 41 0.7× 35 1.5× 43 2.4× 9 0.5× 15 206
Le Thi Kieu Linh Vietnam 9 121 0.9× 42 0.7× 18 0.8× 22 1.2× 79 4.6× 24 191
Houshun Zhu Hong Kong 11 148 1.1× 188 3.2× 72 3.0× 44 2.4× 6 0.4× 11 334
Emanoil Ceaușu Romania 10 109 0.8× 123 2.1× 58 2.4× 21 1.2× 79 4.6× 45 243
Theocharis Tsoleridis United Kingdom 8 133 1.0× 53 0.9× 11 0.5× 16 0.9× 57 3.4× 16 203
Robbert Boudewijns Belgium 8 177 1.3× 39 0.7× 89 3.7× 21 1.2× 3 0.2× 11 219
Romy Weller Germany 5 105 0.8× 75 1.3× 92 3.8× 21 1.2× 78 4.6× 6 221
Hasan Ahmed United States 7 97 0.7× 50 0.9× 13 0.5× 41 2.3× 3 0.2× 17 185
Waleed Aljabr Saudi Arabia 9 85 0.6× 90 1.6× 20 0.8× 30 1.7× 10 0.6× 20 195

Countries citing papers authored by Mami Nagashima

Since Specialization
Citations

This map shows the geographic impact of Mami Nagashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mami Nagashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mami Nagashima more than expected).

Fields of papers citing papers by Mami Nagashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mami Nagashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mami Nagashima. The network helps show where Mami Nagashima may publish in the future.

Co-authorship network of co-authors of Mami Nagashima

This figure shows the co-authorship network connecting the top 25 collaborators of Mami Nagashima. A scholar is included among the top collaborators of Mami Nagashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mami Nagashima. Mami Nagashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Begum, MST Monira, Kimiko Ichihara, Otowa Takahashi, et al.. (2024). Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity. SHILAP Revista de lepidopterología. 4. 5 indexed citations
3.
Islam, Md. Saidul, Masahiro Fukuda, Md Jakir Hossain, et al.. (2023). SARS-CoV-2 suppression depending on the pH of graphene oxide nanosheets. Nanoscale Advances. 5(9). 2413–2417. 5 indexed citations
4.
Suzuki, Manabu, Akihiro Matsunaga, Tohru Miyoshi‐Akiyama, et al.. (2023). Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis of a multicenter, open-label randomized trial. Drug Discoveries & Therapeutics. 17(5). 304–311. 1 indexed citations
5.
Yoshida, Isao, Shinichiro Morioka, Norio Ohmagari, et al.. (2023). Genetic Characteristics of the Virus Detected in the First Mpox Imported Case in Tokyo, Japan. Japanese Journal of Infectious Diseases. 76(4). 259–262. 2 indexed citations
6.
Torii, Shiho, Kwang Su Kim, Jun Koseki, et al.. (2023). Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir. PLoS Pathogens. 19(3). e1011231–e1011231. 13 indexed citations
7.
Sugiyama, Ryuichi, Osamu Takahara, Yuichiro Yahata, et al.. (2023). Nationwide epidemiologic and genetic surveillance of hepatitis E in Japan, 2014–2021. Journal of Medical Virology. 95(6). e28886–e28886. 3 indexed citations
8.
Saito, Sho, Shinya Tsuzuki, Masayuki Shimojima, et al.. (2023). Treatment with tecovirimat of the first two cases of monkeypox in Japan. Journal of Infection and Chemotherapy. 29(4). 418–421.
9.
Honda, Masayuki, Hiroyuki Asakura, Tatsuo Kanda, et al.. (2021). Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan. Viruses. 13(2). 207–207. 7 indexed citations
10.
Yamamoto, Kei, Mami Nagashima, Isao Yoshida, et al.. (2021). Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?. Journal of Infection and Chemotherapy. 27(8). 1273–1275. 3 indexed citations
12.
Akiyama, Yutaro, Noriko Kinoshita, Kenji Sadamasu, et al.. (2021). A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea. Japanese Journal of Infectious Diseases. 75(1). 36–40. 9 indexed citations
13.
Yanagawa, Yasuaki, Mami Nagashima, Hiroyuki Gatanaga, et al.. (2020). Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study. BMJ Open. 10(2). e031605–e031605. 8 indexed citations
14.
Nagashima, Mami, et al.. (2020). Examination of Efficient HIV Confirmatory Testing Protocols Using an HIV-1/2 Antibody Differentiation Assay. Japanese Journal of Infectious Diseases. 73(2). 173–175. 2 indexed citations
15.
Matsuoka, Saori, Mami Nagashima, Kenji Sadamasu, et al.. (2019). Estimating HIV-1 incidence in Japan from the proportion of recent infections. Preventive Medicine Reports. 16. 100994–100994. 9 indexed citations
16.
Ogawa, Satoko, Atsuko Hachiya, Masakazu Matsuda, et al.. (2015). A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis. AIDS Research and Human Retroviruses. 32(3). 284–289. 8 indexed citations
17.
Nagashima, Mami, et al.. (2007). Development of Multiplex Real-time PCR Assay for the Detection of Herpes Simplex Virus Types 1 and 2. Kansenshogaku zasshi. 81(5). 549–554. 4 indexed citations
18.
Sasaki, Yukiko, Akemi Kai, Kenji Sadamasu, et al.. (2006). Multiple Viral Infections and Genomic Divergence among Noroviruses during an Outbreak of Acute Gastroenteritis. Journal of Clinical Microbiology. 44(3). 790–797. 20 indexed citations
19.
Yoshida, Yukiko, et al.. (2005). Genotypic Analysis of Japanese Encephalitis Virus Strains Isolated from Swine in Tokyo, Japan. Japanese Journal of Infectious Diseases. 58(4). 259–261. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026